Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

Bullboard Posts

Next >>

Post by Stockdog12on Jun 19, 2009 1:52pm

334 Views

Post# 16084716

Re HBM News

Peter Jones beat around the bush making promises of JV's and aquisitions and said it would be announced soon, all in all he told us nothing that we already new,the market was looking for something more specific, than promises and HBM'S share price reflected it immediately.

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports